Literature DB >> 33349079

Posterior reversible encephalopathy syndrome induced by food poisoning in a pediatric patient: a case report.

Xue-Mei Wu1, Guang-Liang Wang2, Chang-Gui Kou3, Jiang-Tao Wang1, Jian-Min Liang1, Ya-Qin Yu3.   

Abstract

Posterior reversible encephalopathy syndrome (PRES) can develop in patients following exposure to multiple triggers, including blood pressure fluctuations, kidney diseases, immunosuppressive agents, chemotherapy, or autoimmune disorders. However, to the best of our knowledge, the development of PRES secondary to food poisoning has not been previously reported, especially in a pediatric patient. Here, we report a 13-year-old boy who presented with PRES following the consumption of palmatum (a chicken feet dish). The patient presented with headache, vomiting, and altered consciousness. Neuroimaging findings revealed white matter hyperintensities in a bilateral, symmetrical, and parieto-occipital pattern. The patient was diagnosed with PRES and was managed with fluid expansion and a short-term mannitol regimen (1 g/kg every 12 hours for 3 days). Neuroimaging findings returned to normal at 8 days after admission. Food poisoning may therefore be a new possible trigger for PRES. A timely PRES diagnosis is recommended to prevent possible central nervous system complications.

Entities:  

Keywords:  Posterior reversible encephalopathy syndrome; altered consciousness; food poisoning; headache; pediatric; vomiting; white matter hyperintensities

Mesh:

Year:  2020        PMID: 33349079      PMCID: PMC7758666          DOI: 10.1177/0300060520980201

Source DB:  PubMed          Journal:  J Int Med Res        ISSN: 0300-0605            Impact factor:   1.671


Introduction

Posterior reversible encephalopathy syndrome (PRES) is a clinicoradiological syndrome that was first described in 1996 by Hinchey et al.[1] PRES is a reversible, subcortical, vascular brain edema disease, and is accompanied by a variety of acute nervous system symptoms. The clinical presentation of PRES often encompasses multiple symptoms, including headache, altered consciousness, seizures, and varying degrees of visual impairment.[2] The typical imaging features include subcortical white matter edema. The bilateral parietal and occipital lobes are most frequently involved. Other affected regions include the frontal lobe, temporal lobe, cerebellum, basal ganglia, brainstem, and thalamus. Most lesions are symmetrical, with mild space-occupying effects.[3] To date, a number of triggers, including blood pressure fluctuations, eclampsia, renal diseases, and cytotoxic drugs, have been associated with the development of PRES.[4-7] This study presents a case of PRES in a 13-year-old boy with a history of food poisoning caused by the consumption of palmatum (chicken feet braised with soy sauce). To the best of our knowledge, this is the first report of PRES in a patient with food poisoning.

Case report

A 13-year-old boy was admitted to the First Hospital of Jilin University for evaluation following headache, blurred vision, and trembling for 1 day. The patient ate palmatum 1 day before symptom onset. In addition, the patient’s pets (a cat and a dog) died 1 day after ingesting the palmatum. The patient had an otherwise unremarkable history. His blood pressure was 130/90 mmHg, and other physical examinations were normal. No abnormalities were detected in laboratory tests, a poison screening, ultrasound examination of the heart, electrocardiogram, ambulatory electroencephalogram, or chest radiography. However, magnetic resonance imaging (MRI) revealed high signal intensities in the corpus callosum and posterior areas of the brain (Figure 1). The patient was treated with fluid expansion and a short-term mannitol regimen (1 g/kg every 12 hours for 3 days). After 8 days, the brain MRI abnormalities were mostly resolved. These observations are indicative of PRES. After 1 week, the patient’s clinical symptoms (headache, blurred vision, and trembling) had also disappeared, and the patient was discharged from the hospital with an overall positive prognosis.
Figure 1.

Neuroradiological findings from a 13-year-old boy who presented with headache, blurred vision, and trembling. a: Diffusion-weighted imaging (DWI) showing white matter hyperintensities in the callosum and posterior areas of the brain, correlating with the vasogenic edemas, upon admission. b: DWI demonstrating the disappearance of white matter hyperintensities at 8 days after admission.

Neuroradiological findings from a 13-year-old boy who presented with headache, blurred vision, and trembling. a: Diffusion-weighted imaging (DWI) showing white matter hyperintensities in the callosum and posterior areas of the brain, correlating with the vasogenic edemas, upon admission. b: DWI demonstrating the disappearance of white matter hyperintensities at 8 days after admission.

Discussion

The patient presented with headache, blurred vision, and trembling, which can be caused by elevated blood pressure. The patient’s symptoms resembled the most common clinical features of PRES, as have been previously reported.[1,2] Symptoms with acute or subacute onset usually resolve within hours or days, while other symptoms, such as encephalopathy (50%–80%), epilepsy (60%–75%), headache (50%), visual impairment (33%), focal neurological deficit (10%–15%), and status epilepticus (5%–15%), can last for several weeks.[8,9] Some studies have suggested that an overreaction of cerebrovascular self-regulation mechanisms results in temporary vasospasm and reversible cerebral ischemia.[8,9] Reported cases of PRES have mostly been associated with certain conditions, including hypertension (53%), kidney diseases (45%), malignancy (32%), dialysis dependency (21%), and organ transplantation (24%).[8,9] In addition to the “vasogenic” theory (described in the following paragraph), the pathogenesis of PRES can be closely associated with pathological activation of the immune system, suggesting that a rapid onset of hypertension leads to blood–brain barrier damage, causing vasogenic edema.[2,10] Although PRES triggers have been identified, an increasing number of atypical PRES cases indicate the possible presence of novel, as-yet-unknown triggers.[11-13] In the current report, the patient presented with clinicoradiological findings of PRES following the accidental ingestion of contaminated palmatum. This finding may indicate a novel foodborne trigger for PRES. The failure of cerebral autoregulation following brain edema is a key factor in PRES pathophysiology. Four theories have been postulated to explain the cerebral dysregulation that occurs in PRES.[14] The “vasogenic” theory indicates that an increase in blood pressure might lead to hyperperfusion and vasogenic edema, which in turn can lead to reversible cerebral edema. The “cytotoxic” theory suggests that toxins or chemokines in the blood lead to endothelial dysfunction, which can cause cerebral edema. In the “immunogenic” theory, T-cell activation and cytokines may increase endothelial permeability and vasogenic edema, thus causing cerebral edema. Finally, the “neuropeptide” theory suggests that the release of potent vasoconstrictors might lead to vasospasm and ischemia, and subsequent cerebral edema. In the present report, the pathophysiology of PRES was likely associated with the “cytotoxic” theory because the patient’s pets died after eating the palmatum, which might indicate the presence of certain toxins in the dish. PRES is characterized by headache, disorders of consciousness, visual disturbances, epileptic seizures, and various focal neurological symptoms, all of which resolve within a few hours or days—usually within 3 to 8 days. Distinctive radiological findings of PRES include bilateral subcortical vasogenic edemas, which are reversible in days or weeks, and are located in the occipital and parietal lobes.[15] In the present report, the headache, blurred vision, and trembling symptoms may have been associated with vasogenic edemas; these symptoms had diminished by 3 days after admission. In addition, the patient’s MRI findings were resolved by 8 days following admission. Clinical findings of PRES can vary among patients, and a radiographic examination is therefore essential to confirm the diagnosis. In conclusion, this case report highlights that foodborne factors can possibly trigger PRES. A timely PRES diagnosis, along with prompt and proper treatment, can often lead to a favorable prognosis.
  15 in total

1.  Atypical posterior reversible encephalopathy syndrome associated with chemotherapy with Bevacizumab, Gemcitabine and Cisplatin.

Authors:  R Dersch; O Stich; K Goller; S Meckel; F Dechent; S Doostkam; C Weiller; J Bardutzky
Journal:  J Neurol       Date:  2013-02-21       Impact factor: 4.849

Review 2.  [Posterior reversible encephalopathy syndrome].

Authors:  M Fischer; E Schmutzhard
Journal:  Med Klin Intensivmed Notfmed       Date:  2016-06-06       Impact factor: 0.840

3.  Blood pressure fluctuations in posterior reversible encephalopathy syndrome.

Authors:  Alejandro A Rabinstein; Jay Mandrekar; Ryan Merrell; Osman S Kozak; Olayemi Durosaro; Jennifer E Fugate
Journal:  J Stroke Cerebrovasc Dis       Date:  2011-05-04       Impact factor: 2.136

Review 4.  Posterior reversible encephalopathy syndrome: clinical and radiological manifestations, pathophysiology, and outstanding questions.

Authors:  Jennifer E Fugate; Alejandro A Rabinstein
Journal:  Lancet Neurol       Date:  2015-07-13       Impact factor: 44.182

Review 5.  Posterior reversible encephalopathy syndrome: a review.

Authors:  Steven K Feske
Journal:  Semin Neurol       Date:  2011-05-17       Impact factor: 3.420

6.  Clinical spectrum of reversible posterior leukoencephalopathy syndrome.

Authors:  Vivien H Lee; Eelco F M Wijdicks; Edward M Manno; Alejandro A Rabinstein
Journal:  Arch Neurol       Date:  2008-02

7.  Thrombotic thrombocytopenic purpura with concomitant small- and large-vessel thrombosis, atypical posterior reversible encephalopathy syndrome and cerebral microbleeds.

Authors:  Wong Li Yu; Thomas Leung; Yannie Soo; Jessamyn Lee; Ka Sing Wong
Journal:  Oxf Med Case Reports       Date:  2015-02-03

Review 8.  Posterior reversible encephalopathy syndrome (PRES) induced by pazopanib, a multi-targeting tyrosine kinase inhibitor, in a patient with soft-tissue sarcoma: case report and review of the literature.

Authors:  Shoichi Deguchi; Koichi Mitsuya; Yoko Nakasu; Nakamasa Hayashi; Hirohisa Katagiri; Hideki Murata; Junji Wasa; Mitsuru Takahashi; Masahiro Endo
Journal:  Invest New Drugs       Date:  2017-10-25       Impact factor: 3.850

9.  Clinical, Etiological and Imaging Profile of Posterior Reversible Encephalopathy Syndrome: A Prospective and Follow-Up Study.

Authors:  Saurabh Bansal; Ramandeep Bansal; Manoj Kumar Goyal; Aastha Takkar; Ramandeep Singh; Paramjeet Singh; Vivek Lal
Journal:  Ann Indian Acad Neurol       Date:  2020-02-25       Impact factor: 1.383

Review 10.  Posterior Reversible Encephalopathy Syndrome: Clinical Features and Outcome.

Authors:  Archana Hinduja
Journal:  Front Neurol       Date:  2020-02-14       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.